Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Idiopathic histiocytoid Sweet syndrome with a butterfly rash-like appearance: A confusing case histologically mimicking rosacea-like dermatitis.

Kiyohara T, Shimada S, Ohnishi S, Miyamoto M, Shijimaya T, Nagano N, Nakamaru S, Makimura K, Tanimura H.

J Dermatol. 2019 Sep 25. doi: 10.1111/1346-8138.15097. [Epub ahead of print] No abstract available.

PMID:
31553077
2.

A Potential Application of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Combined with Photodynamic Diagnosis for the Detection of Bladder Carcinoma in Situ: Toward the Future 'MRI-PDD Fusion TURBT'.

Miyake M, Maesaka F, Marugami N, Miyamoto T, Nakai Y, Ohnishi S, Gotoh D, Owari T, Hori S, Morizawa Y, Itami Y, Inoue T, Anai S, Torimoto K, Fujii T, Shimada K, Tanaka N, Fujimoto K.

Diagnostics (Basel). 2019 Sep 4;9(3). pii: E112. doi: 10.3390/diagnostics9030112.

3.

Supplementary granulocyte macrophage colony-stimulating factor to chemotherapy and programmed death-ligand 1 blockade decreases local recurrence after surgery in bladder cancer.

Miyake M, Hori S, Ohnishi S, Toritsuka M, Fujii T, Shimizu T, Owari T, Morizawa Y, Gotoh D, Itami Y, Nakai Y, Anai S, Torimoto K, Tanaka N, Fujimoto K.

Cancer Sci. 2019 Oct;110(10):3315-3327. doi: 10.1111/cas.14158. Epub 2019 Aug 19.

4.

Clinical Impact of the Increase in Immunosuppressive Cell-Related Gene Expression in Urine Sediment during Intravesical Bacillus Calmette-Guérin.

Miyake M, Hori S, Ohnishi S, Owari T, Iida K, Ohnishi K, Morizawa Y, Gotoh D, Itami Y, Nakai Y, Inoue T, Anai S, Torimoto K, Aoki K, Fujii T, Tanaka N, Fujimoto K.

Diseases. 2019 Jun 18;7(2). pii: E44. doi: 10.3390/diseases7020044.

5.

Mycoplasma genitalium Infection and Chronic Inflammation in Human Prostate Cancer: Detection Using Prostatectomy and Needle Biopsy Specimens.

Miyake M, Ohnishi K, Hori S, Nakano A, Nakano R, Yano H, Ohnishi S, Owari T, Morizawa Y, Itami Y, Nakai Y, Inoue T, Anai S, Torimoto K, Tanaka N, Fujii T, Furuya H, Rosser CJ, Fujimoto K.

Cells. 2019 Mar 2;8(3). pii: E212. doi: 10.3390/cells8030212.

6.

Dual benefit of supplementary oral 5-aminolevulinic acid to pelvic radiotherapy in a syngenic prostate cancer model.

Miyake M, Tanaka N, Hori S, Ohnishi S, Takahashi H, Fujii T, Owari T, Ohnishi K, Iida K, Morizawa Y, Gotoh D, Itami Y, Nakai Y, Inoue T, Anai S, Torimoto K, Aoki K, Fujimoto K.

Prostate. 2019 Mar;79(4):340-351. doi: 10.1002/pros.23740. Epub 2018 Nov 18.

PMID:
30450646
7.

Case of photosensitivity after the administration of olmesartan medoxomil.

Ozaki C, Ohnishi S, Yu A, Moriwaki S.

J Dermatol. 2018 Oct;45(10):e277-e278. doi: 10.1111/1346-8138.14310. Epub 2018 Mar 31. No abstract available.

PMID:
29603756
8.

Regulatory T Cells and Tumor-Associated Macrophages in the Tumor Microenvironment in Non-Muscle Invasive Bladder Cancer Treated with Intravesical Bacille Calmette-Guérin: A Long-Term Follow-Up Study of a Japanese Cohort.

Miyake M, Tatsumi Y, Gotoh D, Ohnishi S, Owari T, Iida K, Ohnishi K, Hori S, Morizawa Y, Itami Y, Nakai Y, Inoue T, Anai S, Torimoto K, Aoki K, Shimada K, Konishi N, Tanaka N, Fujimoto K.

Int J Mol Sci. 2017 Oct 19;18(10). pii: E2186. doi: 10.3390/ijms18102186.

9.

Collagen type IV alpha 1 (COL4A1) and collagen type XIII alpha 1 (COL13A1) produced in cancer cells promote tumor budding at the invasion front in human urothelial carcinoma of the bladder.

Miyake M, Hori S, Morizawa Y, Tatsumi Y, Toritsuka M, Ohnishi S, Shimada K, Furuya H, Khadka VS, Deng Y, Ohnishi K, Iida K, Gotoh D, Nakai Y, Inoue T, Anai S, Torimoto K, Aoki K, Tanaka N, Konishi N, Fujimoto K.

Oncotarget. 2017 May 30;8(22):36099-36114. doi: 10.18632/oncotarget.16432.

10.

A multiplex urinary immunoassay for bladder cancer detection: analysis of a Japanese cohort.

Goodison S, Ogawa O, Matsui Y, Kobayashi T, Miyake M, Ohnishi S, Fujimoto K, Dai Y, Shimizu Y, Tsukikawa K, Furuya H, Rosser CJ.

J Transl Med. 2016 Oct 7;14(1):287.

11.

5-fluorouracil enhances the antitumor effect of sorafenib and sunitinib in a xenograft model of human renal cell carcinoma.

Miyake M, Anai S, Fujimoto K, Ohnishi S, Kuwada M, Nakai Y, Inoue T, Tomioka A, Tanaka N, Hirao Y.

Oncol Lett. 2012 Jun;3(6):1195-1202. Epub 2012 Mar 29.

12.

Heme oxygenase-1 promotes angiogenesis in urothelial carcinoma of the urinary bladder.

Miyake M, Fujimoto K, Anai S, Ohnishi S, Kuwada M, Nakai Y, Inoue T, Matsumura Y, Tomioka A, Ikeda T, Tanaka N, Hirao Y.

Oncol Rep. 2011 Mar;25(3):653-60. doi: 10.3892/or.2010.1125. Epub 2010 Dec 27.

PMID:
21206978
13.

Clinical significance of heme oxygenase-1 expression in non-muscle-invasive bladder cancer.

Miyake M, Fujimoto K, Anai S, Ohnishi S, Nakai Y, Inoue T, Matsumura Y, Tomioka A, Ikeda T, Tanaka N, Hirao Y.

Urol Int. 2010;85(3):355-63. doi: 10.1159/000317785. Epub 2010 Aug 21.

PMID:
20733275
14.

Inhibition of heme oxygenase-1 enhances the cytotoxic effect of gemcitabine in urothelial cancer cells.

Miyake M, Fujimoto K, Anai S, Ohnishi S, Nakai Y, Inoue T, Matsumura Y, Tomioka A, Ikeda T, Okajima E, Tanaka N, Hirao Y.

Anticancer Res. 2010 Jun;30(6):2145-52.

PMID:
20651363

Supplemental Content

Loading ...
Support Center